Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Empty antibiotic pipeline critically endangers public: IDSA report.

John S James

    AIDS Treatment News
    |October 16, 2004
    PubMed
    Summary

    The development of new antibiotics is declining due to commercial issues, not scientific ones. This antibiotic resistance crisis threatens public health, making infections potentially fatal.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Activism and online fundraising: overview.

    AIDS treatment news·2007
    Same author

    "Fundathon": toward massively multiplayer online fundraising games.

    AIDS treatment news·2007
    Same authorSame journal

    Selling digital art in bulk through prepaid URLs.

    AIDS treatment news·2007
    Same authorSame journal

    Financial accounts that can reproduce, inherit, and evolve.

    AIDS treatment news·2007
    Same authorSame journal

    AIDS search engine wanted: what to do now?

    AIDS treatment news·2007
    Same author

    Prisoner death rate very high immediately after release.

    AIDS treatment news·2007

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Drug Discovery

    Background:

    • A significant decline in the discovery of novel antibiotics is occurring.
    • This decline is attributed to commercial challenges within the pharmaceutical industry, rather than scientific limitations.

    Discussion:

    • The diminishing pipeline of new antibiotics poses a severe threat to global public health.
    • Increasing bacterial resistance to existing antimicrobial drugs is rendering common infections untreatable.

    Key Insights:

    • The core issue driving the antibiotic shortage is economic, impacting the feasibility of developing new drugs.
    • Without new antibiotics, previously manageable infections risk becoming fatal.

    Outlook:

    • Urgent interventions are needed to address the commercial barriers in antibiotic development.
    • Future public health strategies must prioritize antimicrobial stewardship and novel therapeutic approaches.

    Related Experiment Videos